Turbine was founded for a simple reason; to understand complex cancers better than existing experimental tools in order to solve unmet oncology needs.
Through a multidisciplinary team that unites computer science and molecular biology, and the world's most intricate simulation of cell behavior, we identify treatment options for the 70% of cancers that are currently unexplored.
We use our platform, the Simulated Cell™, to uncover novel biological insights across both new and known targets. This allows us to provide a fresh biological context, define responsive patient populations, and design drug combination approaches that diminish resistance.
With a process proven by clinical stage predictions and a proprietary pipeline, we continue our mission of unlocking cancer complexity to deliver next-generation precision therapeutics.
Through a multidisciplinary team that unites computer science and molecular biology, and the world's most intricate simulation of cell behavior, we identify treatment options for the 70% of cancers that are currently unexplored.
We use our platform, the Simulated Cell™, to uncover novel biological insights across both new and known targets. This allows us to provide a fresh biological context, define responsive patient populations, and design drug combination approaches that diminish resistance.
With a process proven by clinical stage predictions and a proprietary pipeline, we continue our mission of unlocking cancer complexity to deliver next-generation precision therapeutics.
Location: Hungary, Central Hungary, Budapest
Employees: 51-200
Total raised: $59.24M
Founded date: 2015
Founders Related Locations: Hungary, Central Hungary, Budapest
Investors 7
Funding Rounds 4
| Date | Series | Amount | Investors |
| 20.06.2023 | Series A | $27.87M | MassMutual... |
| 02.12.2022 | Series A | $21.08M | Delin Vent... |
| 07.01.2021 | Series A | $6.99M | - |
| 13.11.2019 | Seed | $3.3M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | - | - | CEO, co-fo... | linkedin.c... | - | - |
Mentions in press and media 31
| Date | Title | Description |
| 27.02.2026 | AI Drug Discovery: Turbine Secures $25M to Revolutionize Biopharma with Virtual Biology | Turbine, the innovative virtual biology company based in Budapest, just secured $25 million in Series B funding. This significant capital infusion, spearheaded by Interactive Venture Partners and backed by Beiersdorf Venture Capital, accele... |
| 24.02.2026 | Turbine Raises $25M in Series B Funding | Turbine, a Budapest, Hungary-based virtual biology company, raised $25M in Series B funding. The round was led by Interactive Venture Partners with participation from Beiersdorf Venture Capital. The company intends to use the funds to expan... |
| 17.12.2025 | Accenture Fuels AI Revolution in Clinical Trials | Accenture invests in Ryght AI, leveraging agentic AI and digital twins to transform clinical trials. This strategic move targets inefficiencies in site selection and patient recruitment, aiming to accelerate drug development. It promises to... |
| 13.12.2025 | Accenture Invests In Ryght AI To Accelerate Agentic AI–Driven Clinical Research And Trial Execution | Accenture has made a strategic investment in Ryght AI, a platform provider focused on modernizing how clinical research is designed and executed across the life sciences industry, as enterprise demand for agentic AI continues to accelerate ... |
| 22.08.2025 | Why most AI drug discovery startups struggle — and how Turbine plans to beat the odds | Countless resources and time are expended globally to research and advance novel therapies that end in clinical failure and no patient benefit. Imagine a world where it is possible to predict any potential drug’s effect on translatable biol... |
| 01.05.2025 | Changes amidst challenges: Hungary’s tech ecosystem | Hungary’s tech ecosystem reflects a complex yet promising landscape shaped by global headwinds, regional resilience, and targeted national strategies. Although startup funding stagnated in 2024, early-stage ventures demonstrated notable str... |
| 26.09.2024 | The Hungarian tech surge: Where global investments meet local expertise | The Hungarian technology ecosystem is experiencing rapid growth and development, showcasing a wealth of strengths. The country is home to several mature tech companies, while an increasing number of tech firms are attracting investment from... |
| 17.05.2024 | Turbine Receives Investment from Accenture | Turbine, a Budapest, Hungary-based predictive simulation company that is building a platform for interpreting human biology, received an investment from Accenture (NYSE: ACN), through Accenture Ventures. The amount of the deal was not discl... |
| 16.05.2024 | Accenture Backs Turbine’s AI-Powered Platform to Accelerate Drug Discovery | What You Should Know: – Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development. – The investment aims to em... |
| 13.03.2024 | Over €500M raised by EIT Health Gold Track alumni | Over the last four years, EIT Health’s Gold Track Programme, run in partnership with Advise Connect Inspire LLC, has paired top-flight European start-ups with world-class life science advisors to accelerate their growth, unlocking ambitious... |
Show more